Amicus Therapeutics, Inc. (FOLD) by event type

FOLD moves most on analyst upgrades — a median of -0.58% at 30 minutes across 18 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the FOLD overview →

By event type

How FOLD reacts across 4 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
2,438 of 2,717
18-0.58%33%-0.53%
Analyst downgrades
1,523 of 2,603
26-0.04%42%-0.23%
Rating reiterations
2,856 of 3,522
41-0.17%39%-0.35%
Price-target raises
1,249 of 1,790
10-0.07%40%-0.94%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.

That’s how FOLD usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · FOLD overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
ARADIGM CORP COMMON STOCK (ARDM)3840.00%39%
HISTOGENICS CORP COMMON (HSGX)383-0.30%35%
CORIUM INTL (CORI)3800.00%46%
PROTEON THERAPEUTICS (PRTO)3800.00%39%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.